Penumbra PEN
NYSE PEN
$325.12 -1.72 (-0.53%)
At close: Aug 20, 2026 · 1:08 PM UTC

Penumbra (PEN) FCF Margin (2014 - 2026)

Penumbra (PEN) posted quarterly FCF Margin of 8.34% for Q2 2026, down 31.0% year-over-year from 12.09% in Q2 2025, and down 57.34% quarter-over-quarter from 19.56% in Q1 2026.

Penumbra (PEN) FCF Margin (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported FCF Margin for 13 consecutive years, with 8.34% the latest figure, recorded in Q2 2026.

  • In Q2 2026, FCF Margin fell 31.0% year-over-year to 8.34%; the TTM figure through Jun 2026 stood at 14.35% (up 172.0% YoY), while the FY2025 annual figure was 12.46%, up 13.0% from the prior year.
  • FCF Margin eased to 8.34% in Q2 2026 per PEN's latest filing, from 19.56% in the prior quarter.
  • Across five years, FCF Margin topped out at 19.56% in Q1 2026 and bottomed at 21.12% in Q2 2022.
  • Historically, FCF Margin has averaged 6.7% across 5 years, with a median of 9.4% in 2023.
  • Annual changes were most pronounced in 2022 — FCF Margin tumbled 2513 bps — and 2023, when it jumped 2600 bps.
  • Penumbra's FCF Margin stood at 1.01% in 2022, then jumped by 1239 bps to 11.46% in 2023, then advanced by 27 bps to 14.5% in 2024, then increased by 22 bps to 17.66% in 2025, then sank by 53 bps to 8.34% in 2026.
  • Business Quant data shows PEN's FCF Margin at 8.34% in Q2 2026, 19.56% in Q1 2026, and 17.66% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 15.81%
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 16.07%
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 21.26%
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 23.50%
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 33.60%
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn 14.10%
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 1.28%
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 5.32%
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 18.73%
10 Penumbra 12.79 Bn 12.13 Bn 264.94 Mn 8.34%

Historic Data

Download Data
DateValue
Jun 30, 2026 8.34%
Mar 31, 2026 20.06%
Dec 31, 2025 21.47%
Sep 30, 2025 24.18%
Jun 30, 2025 5.19%
Mar 31, 2025 14.57%
Dec 31, 2024 14.50%
Sep 30, 2024 16.95%
Jun 30, 2024 6.04%
Mar 31, 2024 11.65%
Dec 31, 2023 12.77%
Sep 30, 2023 11.46%
Jun 30, 2023 6.66%
Mar 31, 2023 4.70%
Dec 31, 2022 6.68%
Sep 30, 2022 -9.01%
Jun 30, 2022 -21.12%
Mar 31, 2022 -4.65%
Dec 31, 2021 -12.55%
Sep 30, 2021 17.80%